Despite a raging opiate epidemic that has left countless Americans dead, pharmaceutical companies continue to rail against cannabis for being an unsafe and unproven medication.

DEA Approves Synthetic Cannabis Medication by Anti-Cannabis Pharmaceutical Giant

The Drug Enforcement Administration has approved Syndros, a cannabis-based medication developed by pharmaceutical company Insys Therapeutics, for Schedule II status under the … Continue reading DEA Approves Synthetic Cannabis Medication by Anti-Cannabis Pharmaceutical Giant

Ganjapreneur.com